🇺🇸 FDA
Patent

US 7378276

Method of inducing memory B cell development and terminal differentiation

granted A61KA61K2035/124A61K35/17

Quick answer

US patent 7378276 (Method of inducing memory B cell development and terminal differentiation) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2035/124, A61K35/17, A61K38/20, A61K40/13